|
|
|
08220
|
|
|
P.I.:
|
Marianna Koczywas, MD
|
|
|
Title:
|
Randomized, Open-Label, Phase 3 Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer
|
| | |
|
|
08141
|
|
|
P.I.:
|
Marianna Koczywas, MD
|
|
|
Title:
|
Phase 3 Study of Pemetrexed, Cisplatin and Radiotherapy followed by Consolidation Pemetrexed v Etoposide, Cisplatin and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectable, Locally Advanced, Stage III NSCLC Other than Predominantly Squamous Cell Histology
|
| | |
|
|
08105
|
|
|
P.I.:
|
Marianna Koczywas, MD
|
|
|
Title:
|
Phase I/II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin in Patients with Advanced Solid Tumors and in Chemotherapy-Naive Patients with Malignant Pleural Mesothelioma
|
| | |
|
|
06094
|
|
|
P.I.:
|
Marianna Koczywas, MD
|
|
|
Title:
|
PHII-65 NCI #7103: A Phase II Study of AZD2171 (NSC #732208)in Patients with Malignant Mesothelioma
|
| | |
|
|
06022
|
|
|
P.I.:
|
Marianna Koczywas, MD
|
|
|
Title:
|
PHI-55 NCI#7427: A Phase I Study of Halichondrin B Analog (E7389) in Combination with Cisplatin in Advanced Solid Tumors
|
| | |
|